BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29565196)

  • 1. Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development.
    Seo J; Smith BD; Estey E; Voyard E; O' Donoghue B; Bridges JFP
    Curr Med Res Opin; 2018 Dec; 34(12):2031-2039. PubMed ID: 29565196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia.
    Bridges JF; Oakes AH; Reinhart CA; Voyard E; O'Donoghue B
    Patient Prefer Adherence; 2018; 12():647-655. PubMed ID: 29731612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.
    Richardson DR; Crossnohere NL; Seo J; Estey E; O'Donoghue B; Smith BD; Bridges JFP
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):942-948. PubMed ID: 32132149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.
    Peay HL; Hollin I; Fischer R; Bridges JF
    Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects from acute myeloid leukemia treatment: results from a national survey.
    Crossnohere NL; Richardson DR; Reinhart C; O'Donoghue B; Love SM; Smith BD; Bridges JFP
    Curr Med Res Opin; 2019 Nov; 35(11):1965-1970. PubMed ID: 31188058
    [No Abstract]   [Full Text] [Related]  

  • 6. Prioritizing the worries of AML patients: Quantifying patient experience using best-worst scaling.
    Richardson DR; Oakes AH; Crossnohere NL; Rathsmill G; Reinhart C; O'Donoghue B; Bridges JFP
    Psychooncology; 2021 Jul; 30(7):1104-1111. PubMed ID: 33544421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event.
    Bridges JFP; Tsai JH; Janssen E; Crossnohere NL; Fischer R; Peay H
    Patient; 2019 Apr; 12(2):247-257. PubMed ID: 30259384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care Management for Youth With Comorbid Developmental and Mental Health Conditions: A Discrete Choice Experiment Pilot Study.
    dosReis S; N'Dri L; Ross M; Camelo Castillo W; Reeves G; Butler B
    Acad Pediatr; 2020 Mar; 20(2):241-249. PubMed ID: 31128382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes.
    Janssen EM; Segal JB; Bridges JF
    Patient; 2016 Oct; 9(5):465-79. PubMed ID: 27120338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and caregiver preferences for the potential benefits and risks of a seizure forecasting device: A best-worst scaling.
    Janse SA; Dumanis SB; Huwig T; Hyman S; Fureman BE; Bridges JFP
    Epilepsy Behav; 2019 Jul; 96():183-191. PubMed ID: 31150998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preferences, regret, and health-related quality of life among older adults with acute myeloid leukemia: A pilot longitudinal study.
    LoCastro M; Wang Y; Sanapala C; Jensen-Battaglia M; Wittink M; Norton S; Klepin HD; Richardson DR; Mendler JH; Liesveld J; Huselton E; Loh KP
    J Geriatr Oncol; 2023 Jun; 14(5):101529. PubMed ID: 37244139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
    Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
    Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
    Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
    Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease.
    Collacott H; Zhang D; Heidenreich S; Tervonen T
    Patient; 2022 Jan; 15(1):55-68. PubMed ID: 34250574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-centered communication tool for older patients with acute myeloid leukemia, their caregivers, and oncologists: A single-arm pilot study.
    LoCastro M; Sanapala C; Wang Y; Jensen-Battaglia M; Wittink M; Norton S; Klepin HD; Richardson DR; Mendler JH; Liesveld J; Huselton E; O'Dwyer K; Cortes AM; Rodriguez C; Dale W; Loh KP
    Cancer Med; 2023 Apr; 12(7):8581-8593. PubMed ID: 36533397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.
    Crawford R; Sully K; Conroy R; Johnson C; Doward L; Bell T; Welch V; Peloquin F; Gater A
    Patient; 2020 Feb; 13(1):83-102. PubMed ID: 31456136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduce mortality risk above all else: a discrete-choice experiment in acute coronary syndrome patients.
    Mühlbacher AC; Bethge S
    Pharmacoeconomics; 2015 Jan; 33(1):71-81. PubMed ID: 25342231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health state utilities associated with treatment options for acute myeloid leukemia (AML).
    Matza LS; Deger KA; Howell TA; Koetter K; Yeager AM; Hogge D; Fisher V; Louie AC; Chung KC
    J Med Econ; 2019 Jun; 22(6):567-576. PubMed ID: 30775943
    [No Abstract]   [Full Text] [Related]  

  • 20. Using Social Media to Uncover Treatment Experiences and Decisions in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Are Ineligible for Intensive Chemotherapy: Patient-Centric Qualitative Data Analysis.
    Booth A; Bell T; Halhol S; Pan S; Welch V; Merinopoulou E; Lambrelli D; Cox A
    J Med Internet Res; 2019 Nov; 21(11):e14285. PubMed ID: 31755871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.